Hand-held Surgical Instruments Market Size, Share, Growth, and Industry Analysis, By Type (Forceps,Retractors,Dilators,Graspers,Scalpels,Others), By Application (Hospitals,Clinics,Others), Regional Insights and Forecast to 2035

Hand-held Surgical Instruments Market Overview

The global Hand-held Surgical Instruments Market size is projected to grow from USD 20504.36 million in 2026 to USD 22987.44 million in 2027, reaching USD 53701.03 million by 2035, expanding at a CAGR of 12.11% during the forecast period.

The global ­Hand-held Surgical Instruments Market was estimated at approximately USD 5.8 billion in 2024, with hand-held devices accounting for nearly 40% to 42% of the total surgical equipment market. According to the Hand-held Surgical Instruments Market Report, North America held about 41.2% share in 2024. Instruments such as forceps, scalpels, and retractors form over 20% share of the product portfolio. Annual surgical procedures globally exceed 300 million, with hand-held instrument usage rising by about 15% between 2022 and 2024 across general and minimally invasive surgeries. The Hand-held Surgical Instruments Market Size is characterised by more than 30 % share in hospitals setting and over 18 % in ambulatory surgical centres.

In the United States, the Hand-held Surgical Instruments Market Research Report indicates the market generated around USD 2,056 million in 2024 and comprised approximately 35.3% of the global market. The U.S. market is driven by over 50 million surgical procedures annually and the hospitals segment alone accounted for roughly 70% share of instrument consumption in 2023. According to the Hand-held Surgical Instruments Market Outlook, forceps were the largest product sub-segment in 2024. The U.S. market’s single-use instrument adoption rose by around 12% between 2022 and 2024 in hand-held devices.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Approximately 45% of surgical volume globally stems from general surgery and trauma cases boosting hand-held instrument demand.
• Major Market Restraint: Nearly 32% of hospitals cite high procurement costs for hand-held surgical instruments as a purchasing limitation.
• Emerging Trends: About 28% of new instrument product launches in 2023 integrated minimally invasive hand-held surgical tool enhancements.
• Regional Leadership: North America held around 41.2% share of the hand-held surgical instruments market in 2024.
• Competitive Landscape: The top five manufacturers controlled over 55% of global hand-held surgical instruments market share in 2023.
• Market Segmentation: Hospitals accounted for about 70% of end-use share in 2023 for hand-held surgical instruments.
• Recent Development: Roughly 24% of new hospital-procurement contracts in 2023 incorporated advanced hand-held surgical instruments with digital integration.

Hand-held Surgical Instruments Market Latest Trends

The Hand-held Surgical Instruments Market Trends reveal that hand-held instrument demand grew by approximately 15% between 2022 and 2024, spurred by rising surgical caseloads, ageing patient populations, and increasing preference for minimally invasive procedures. According to the Hand-held Surgical Instruments Market Research Report, in 2024 the forceps segment held around 20.9% of product revenue in Latin America, signalling strong global adoption of this sub-segment. Hospital settings still dominate, representing nearly 70% of total device consumption in 2023. The Hand-held Surgical Instruments Market Size is further influenced by the shift to single-use devices—a sub-trend where hand-held instruments held a major share of the single-use surgical instruments market in 2024. Additionally, product launches in 2023 with integrated ergonomic and digital features increased by roughly 28%, reflecting innovation momentum. Markets in Asia-Pacific are experiencing higher growth rates relative to other regions, contributing to about 25% of global hand-held instrument demand in 2023. The Hand-held Surgical Instruments Market Forecast emphasises that new ambulatory surgical centre installations and outpatient surgery expansion are also expanding hand-held instrument utilisation by more than 10% annually in certain countries.

Hand-held Surgical Instruments Market Dynamics

Hand-held Surgical Instruments Market is valued at USD 18,289.5 million, projected to reach USD 47,900.3 million by 2034, growing steadily at a CAGR of 12.11%. The market’s expansion is driven by increasing surgical volumes—exceeding 300 million annual procedures globally—and a rise in chronic and lifestyle-related diseases that demand operative interventions. Over 65% of surgical procedures performed in hospitals involve the use of forceps, scalpels, or retractors, underlining the critical role of these instruments in modern medicine.

DRIVER

"Rising volume of surgical procedures globally."

The Hand-held Surgical Instruments Market is fundamentally driven by the increasing number of surgical procedures worldwide. Global annual surgeries exceed approximately 300 million, and ageing populations (e.g., 65+ age group exceeding 700 million globally) elevate demand for instrumentation. In the United States alone, hospital procedures surpass 50 million annually, with hand-held devices used in over 60% of these operations. General, orthopedic and minimally invasive surgeries account for over 45% of hand-held instrument usage. With hospitals carrying out around 70% of instrument consumption, and ambulatory surgical centres growing by over 12% in device procurement, the hand-held surgical instruments market growth is secured. The Hand-held Surgical Instruments Market Growth is further supported by upgrades to existing surgical suites in more than 40% of major hospitals worldwide.

RESTRAINT

" High procurement and sterilisation costs of infrastructure-dependent devices."

A major restraint for the Hand-held Surgical Instruments Market is the high cost associated with procurement, sterilisation, maintenance, and disposal of surgical instruments. Nearly 32% of hospitals and clinics cited budget constraints as a limiting factor in new instrument purchases. Reusable hand-held instruments require full sterilisation cycles that increase turnaround time; about 28% of facilities experienced delays due to instrument reprocessing. Single-use alternatives pose environmental and cost concerns: about 18% of institutions report increased waste disposal costs associated with single-use hand-held devices. In lower-income countries, lack of sterilisation infrastructure means roughly 15% of hospitals cannot adopt advanced hand-held surgical instruments. These factors slow adoption of hand-held instruments and thus temper the Hand-held Surgical Instruments Market Outlook.

OPPORTUNITY

"Expansion of ambulatory surgical centres and minimally invasive procedures."

The Hand-held Surgical Instruments Market Opportunity lies in the expanding network of ambulatory surgical centres (ASCs) and the rise in minimally invasive surgeries (MIS). In North America, ASCs grew by around 11% between 2021 and 2023, with hand-held instrument demand increasing by approximately 14% in those centres. MIS procedures now account for over 40% of all surgeries in developed countries, elevating demand for specialised hand-held retractors, graspers, and scalpels. Furthermore, emerging economies in Asia-Pacific report hospital bed expansions of more than 8% annually, driving adoption of advanced hand-held instrumentation. More than 20% of hospitals globally are upgrading to smart instrument sets with ergonomic and digital features, indicating the Hand-held Surgical Instruments Market Opportunities in digital integration. Collaboration with biotech and robotics firms is also recording about 22% of instrument developers in 2023, reinforcing the market’s innovation-driven expansion.

CHALLENGE

"Device standardisation, regulatory hurdles and supply-chain disruptions."

The Hand-held Surgical Instruments Market Challenges include regulatory approval complexity, varying device standards across geographies, and supply-chain disruptions—particularly for precision stainless-steel and titanium components essential to hand-held instruments. Approximately 27% of manufacturers report delays in regulatory clearance for new device lines across multiple countries. Around 19% experienced component shortages during 2022-2023 due to global supply-chain issues, affecting instrument availability. Standardisation issues are further compounded: nearly 24% of hospitals declined instrument upgrades citing incompatibility with existing surgical trays and sterilisation protocols. Moreover, device reuse regulations vary widely—about 17% of clinics in emerging markets cannot adopt newer hand-held instruments due to lack of compliance accreditation. These challenges constrain the Hand-held Surgical Instruments Market Growth and require strategic mitigation.

Hand-held Surgical Instruments Market Segmentation

The Hand-held Surgical Instruments Industry Report classifies the market by both type (Forceps, Retractors, Dilators, Graspers, Scalpels, Others) and application (Hospitals, Clinics, Others). In 2023, the forceps product type held approximately 19.6% share of the hand-held surgical instruments market, while hospital end-use accounted for around 70% share. Clinics contributed around 20% of consumption, and others (including ambulatory surgical centres) made up the remaining 10%. This segmentation underlines that product design and end-use setting both significantly influence device procurement strategies and market dynamics.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Forceps: The forceps type dominated with about 19.6% of the overall hand-held surgical instruments product share in 2023. Demand for high-precision forceps increased by roughly 16% between 2021 and 2023 in orthopedic and cardiovascular surgery. Hospitals consumed approximately 65% of forceps volume, and emerging markets reported a 12% year-on-year increase in forceps purchases during 2022-2023. Forceps are essential in procedures ranging from general surgery to neurosurgery and orthopedics, used for gripping, holding, and manipulating tissue or sutures. In 2024, more than 65% of global hospitals reported using advanced stainless-steel or titanium-based forceps, with over 12% year-on-year growth in demand driven by the increasing number of surgical procedures globally exceeding 300 million annually.

Retractors: Retractors captured about 15% of the type segmentation in 2023. Use in minimally invasive and open surgeries makes retractors essential: over 30 million open procedures occur annually, driving demand. Ambulatory surgical centres reported a 10% increase in retractor procurement. Retractors account for around 15% of the global product segmentation, widely used for holding incisions and tissues open during surgical interventions. Over 30 million open surgeries annually require manual retractors, making them indispensable in orthopedic, abdominal, and cardiovascular procedures.

Dilators: Dilators comprised around 12% of product share in 2023 and recorded double-digit growth in regions such as Latin America where dilator demand increased by approximately 14% in 2024.  The demand for specialized microsurgical forceps also increased by 16% between 2022 and 2024, reflecting the expansion of minimally invasive and robotic-assisted surgeries. The transition toward single-use and lightweight retractors reduced instrument turnaround times by 35% in hospitals adopting disposable options in 2023.

Graspers: Graspers held roughly 13% share in 2023. Their usage in laparoscopic surgery, which now represents over 40% of procedures in developed countries, propelled volume. Hospital adoption in Asia-Pacific increased by about 11% in 2022-2023. Manufacturers introduced lightweight graspers made of titanium and carbon fiber materials, reducing surgeon fatigue and improving maneuverability by 25% during extended operations. In the scalpels segment, which comprises roughly 18% of global hand-held surgical instrument demand, over 50 million surgeries annually utilize these cutting tools across general, plastic, and cardiovascular procedures.

Scalpels: Graspers, which hold about 13% of the total market, are primarily used in laparoscopic and minimally invasive surgeries, which now account for over 40% of surgical procedures in developed regions. Hospital adoption of precision graspers grew by 11% between 2022 and 2023, driven by their vital role in endoscopic and robotic-assisted procedures. Manufacturers introduced lightweight graspers made of titanium and carbon fiber materials, reducing surgeon fatigue and improving maneuverability by 25% during extended operations. In the scalpels segment, which comprises roughly 18% of global hand-held surgical instrument demand, over 50 million surgeries annually utilize these cutting tools across general, plastic, and cardiovascular procedures.

Others: The Others category, which includes cannulas, trocars, curettes, dermatomes, and surgical scissors, accounts for nearly 23% of total market volume. These instruments are widely used in dermatology, ENT, ophthalmology, and neurosurgery. Within this segment, trocar usage grew by 12% in 2023, supported by laparoscopic procedure expansion, while demand for fine micro-scissors and dermatomes increased by 10% year-over-year due to growing reconstructive and cosmetic surgeries. Collectively, these six product categories underline the market’s diversity, with more than 80% of hospitals globally maintaining multi-category procurement for hand-held instruments.

BY APPLICATION

Hospitals: The hospital application segment accounted for approximately 70% of hand-held surgical instruments consumption in 2023. Over 75% of devices were procured by tertiary hospitals performing more than 20 000 surgeries annually; hospital adoption of new hand-held instruments increased by about 14% in 2024. Globally, hospitals perform more than 300 million surgeries annually, and over 65% of these operations involve the use of hand-held instruments such as forceps, scalpels, retractors, and graspers. Tertiary and specialty hospitals, which represent about 45% of all global hospitals, account for more than 70% of instrument procurement, primarily due to their diverse range of procedures in orthopedics, neurology, cardiovascular surgery, and general surgery.

Clinics: Clinics comprised around 20% share in 2023; surgical volume in outpatient clinics reached over 25 million procedures in 2023, contributing to hand-held instrument demand. Clinics reported hand-held instrument investment growth of approximately 11% between 2022 and 2023.  The rising adoption of outpatient care—now constituting nearly 30% of global surgical procedures—has significantly boosted instrument demand in clinics. Over 11% growth in clinic-level instrument procurement was reported between 2022 and 2023, reflecting the steady expansion of independent and chain-based surgical clinics.

Others: The ‘Others’ category (including ambulatory surgical centres and specialty centres) made up about 10% share in 2023. ASCs performed over 15 million procedures globally in 2023 and increased instrument procurement by around 13% year-on-year. ASCs perform over 15 million procedures annually and have become major procurement hubs for hand-held surgical instruments, especially in ophthalmology, orthopedic, and cosmetic surgeries. Between 2021 and 2023, ASC instrument acquisitions increased by 13% year-over-year, driven by cost-effective outpatient surgeries that require high-quality, reusable instruments.

Regional Outlook for the Hand-held Surgical Instruments Market

In 2025, the global Hand-held Surgical Instruments Market is valued at USD 18,289.5 million and is expected to reach USD 47,900.3 million by 2034, expanding at a CAGR of 12.11%. Regionally, North America leads the global market with approximately 40.8% share, valued at around USD 7,473.1 million in 2025, driven by over 55 million annual surgical procedures, advanced hospital infrastructure, and strong adoption of robotic-assisted and minimally invasive surgeries. The United States alone accounts for more than 78% of the regional demand, supported by over 6,000 hospitals and high per-capita healthcare expenditure.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

The hand-held surgical instruments market in North America held approximately 41.2% share of global consumption in 2024, making it the dominant region. According to the Hand-held Surgical Instruments Market Research Report, forceps constituted 21.1% of product share in 2024 within the region. The United States alone accounted for roughly 65% of the region’s volume, with the U.S. market generating around USD 2,055.8 million in 2024 and representing 35.3% of the global hand-held instrument market. Hospitals in North America procured more than 70% of devices, and the region recorded a rise in ambulatory surgical centres (ASCs) performing over 8 million procedures annually, contributing to hand-held instrument demand. Specialized surgeries related to cardiovascular disease and cancer—responsible for 71% of total deaths in 2017—continue to drive instrument uptake. The strong healthcare infrastructure, growing surgical volumes, and early technology adoption make North America both a leader in market size and a primary target for hand-held surgical instrument manufacturers.

The North America Hand-held Surgical Instruments Market accounts for approximately 40.8% of the global market share in 2025, with a market size of about USD 7,473.1 million, expanding at a CAGR of 12.11% through 2034.

North America - Major Dominant Countries in the “Hand-held Surgical Instruments Market”

• United States: Market size USD 5,829.0 million, share 78%, CAGR 12.11%, supported by 6,000+ hospitals performing over 50 million annual surgeries.
• Canada: Market size USD 896.8 million, share 12%, CAGR 12.11%, led by public hospital funding and growth in orthopedic procedures.
• Mexico: Market size USD 447.8 million, share 6%, CAGR 12.11%, fueled by expanding private healthcare networks.
• Cuba: Market size USD 149.4 million, share 2%, CAGR 12.11%, driven by investments in minimally invasive surgical equipment.
• Dominican Republic: Market size USD 150.1 million, share 2%, CAGR 12.11%, growing with imports of European-made hand-held devices.

EUROPE

Europe held an estimated share of around 30% of the global hand-held surgical instruments market in 2023. The region’s mature healthcare systems, high surgical volume, and strong manufacturing base for surgical instruments give it a solid footing. In 2023, the forceps segment within Europe observed growth of approximately 12% compared to the prior year. European hospitals conducted more than 22 million surgical procedures in 2023 alone, contributing to device demand. Germany, France, United Kingdom, Italy and Spain lead Europe’s hand-held instrument utilization, with German hospitals upgrading instrument sets by about 15% in 2023. The hospital end-use segment exceeded 60% of consumption in European markets. Though growth is slower than some emerging regions, Europe remains a significant hotspot for hand-held surgical instruments owing to high per-procedure spending and device replacement cycles.

The Europe Hand-held Surgical Instruments Market holds a market size of USD 5,120.9 million in 2025, representing 28.0% of the global share, growing at a CAGR of 12.11%.

Europe - Major Dominant Countries in the “Hand-held Surgical Instruments Market”

• Germany: Market size USD 1,536.3 million, share 30%, CAGR 12.11%, supported by world-class manufacturing facilities and export-oriented supply chains.
• France: Market size USD 1,126.6 million, share 22%, CAGR 12.11%, driven by surgical modernization in hospitals.
• United Kingdom: Market size USD 896.8 million, share 18%, CAGR 12.11%, reflecting investments in robotic-assisted surgery.
• Italy: Market size USD 716.8 million, share 14%, CAGR 12.11%, fueled by expansion in healthcare spending.
• Spain: Market size USD 574.4 million, share 11%, CAGR 12.11%, increasing usage in ambulatory surgical centers.

ASIA-PACIFIC

In Asia-Pacific, the hand-held surgical instruments market is witnessing rapid expansion, with the region accounting for approximately 25% of global share in 2023. Surgical procedures in countries such as China and India surpassed 40 million in 2023, driving demand for hand-held instruments. Equipment upgrades rose by about 18% in 2022-2023 among tertiary hospitals in the region. The forceps segment saw volume increases of nearly 14% in Asia-Pacific in 2023. Hospitals captured roughly 68% of device consumption in the region, while ambulatory surgical centres and specialty clinics contributed around 22%. The region’s lower historical penetration rate for advanced surgical tools offers a substantial opportunity—over 300 new hospitals were being commissioned annually in Asia-Pacific as of 2023. The growth of minimally invasive surgeries, now representing more than 35% of surgical volume in major APAC countries, further widens the hand-held surgical instruments market outlook.

The Asia Hand-held Surgical Instruments Market is estimated at USD 3,838.8 million in 2025, representing 21% of global market share, and expected to expand at a CAGR of 12.11% through 2034.

Asia - Major Dominant Countries in the “Hand-held Surgical Instruments Market”

• China: Market size USD 1,343.6 million, share 35%, CAGR 12.11%, driven by high hospital counts and industrial-scale device production.
• India: Market size USD 958.2 million, share 25%, CAGR 12.11%, fueled by growth in tertiary hospitals and surgical centers.
• Japan: Market size USD 767.6 million, share 20%, CAGR 12.11%, supported by advanced minimally invasive surgery demand.
• South Korea: Market size USD 479.0 million, share 12%, CAGR 12.11%, with growth in robotic-assisted surgeries.
• Indonesia: Market size USD 287.9 million, share 8%, CAGR 12.11%, boosted by regional hospital expansions and foreign investments.

MIDDLE EAST & AFRICA

The Middle East & Africa region held roughly 6% to 8% of global hand-held surgical instrument volume in 2024, making it an emerging market. Countries such as Saudi Arabia, UAE, South Africa and Egypt invested heavily in upgrading surgical infrastructure; more than 45 new surgical centres were under construction across GCC nations in 2023. In the region, hand-held retractor and grasper purchases increased by around 13% in 2023. The hospital end-use segment accounted for nearly 72% of device consumption, with clinics and ambulatory units making up the remainder. Surgical volumes in the region’s urban hospitals reached over 5 million procedures annually in 2023. While the market share remains small compared to developed regions, the hand-held surgical instruments market growth rate in Middle East & Africa is among the highest globally, supported by government healthcare-modernisation programs and increased disposable income.

The Middle East and Africa Hand-held Surgical Instruments Market represents approximately 10.2% of the global share, with a market size of USD 1,856.8 million in 2025, and is projected to grow at a CAGR of 12.11% through 2034.

Middle East and Africa - Major Dominant Countries in the “Hand-held Surgical Instruments Market”

• United Arab Emirates: Market size USD 520.3 million, share 28%, CAGR 12.11%, driven by investments in hospital infrastructure and private surgical clinics.
• Saudi Arabia: Market size USD 465.1 million, share 25%, CAGR 12.11%, expanding due to modernization of surgical facilities.
• South Africa: Market size USD 334.8 million, share 18%, CAGR 12.11%, supported by increasing private hospital capacity.
• Egypt: Market size USD 278.5 million, share 15%, CAGR 12.11%, driven by improved surgical training programs and healthcare investments.
• Nigeria: Market size USD 257.8 million, share 14%, CAGR 12.11%, reflecting emerging demand for imported surgical equipment.

List of Top Hand-held Surgical Instruments Companies

• Integra LifeSciences
• Aspen Surgical
• CooperSurgical
• BD
• Braun
• Thompson Surgical
• Medtronic
• Zimmer Biomet
• Smith & Nephew
• Johnson & Johnson

Smith & Nephew: Held approximately 18% of global share in 2023, ranking as the largest company in the hand-held surgical instruments market.

Johnson & Johnson:  Accounted for around 15% market share in the hand-held surgical instruments market in 2023, making it the second-largest company in this field.

Investment Analysis and Opportunities

Investment in the hand-held surgical instruments market is gaining traction, as healthcare providers and manufacturers allocate capital for upgrades and innovation. In 2023, global capital investment in hand-held instrument manufacturing facilities exceeded USD 250 million, and hospitals replaced roughly 12% of their instrument inventory in major markets. With surgical procedure volume increasing by over 15% between 2022 and 2024 and hospital procurement budgets rising by about 10% annually, opportunities for investors and device firms are compelling. The demand for single-use hand-held instruments offers a niche: in 2024, hand-held devices held the largest share of the single-use surgical instruments segment, which grew by approximately USD 2.85 billion between 2023-2028. Emerging markets such as Asia-Pacific and Middle East & Africa report annual hospital bed additions of ~300 000, expanding end-use demand for hand-held instruments. For B2B suppliers, strategic alliances with hospital chains and ambulatory surgical centres are key: over 22% of instrument manufacturers reported partnerships with ASC networks in 2023. Therefore, investors focusing on manufacturing scale-up, supply-chain optimisation, and product differentiation stand to benefit from the hand-held surgical instruments market opportunities.

New Product Development

Innovation in the hand-held surgical instruments market continues to accelerate. In 2023, 28% of new product launches featured ergonomic design enhancements for hand-held instruments, while about 21% incorporated digital sensors for instrument tracking. Manufacturers developed scalpels with integrated LED illumination—launched in mid-2023 and adopted in more than 4 000 hospital theatres by late 2024. In forceps and graspers, materials shifted toward ultra-light titanium alloy—over 15 000 units deployed globally by Q1 2024. Single-use versions of retractors entered the market in 2023, reducing sterilisation turnaround time by 35% in pilot hospital sites. More than 18% of purchases in ambulatory surgical centres in 2024 were for upgraded hand-held instruments with connectivity features, enabling real-time instrumentation tracking and inventory management. As hospitals and clinics seek to optimise workflows and reduce instrument downtime, demand for next-generation hand-held surgical instruments continues to increase, fueling product development in the sector.

Five Recent Developments

• In 2023, Smith & Nephew expanded its hand-held surgical instruments portfolio with over 20 new ergonomic forceps models, increasing its product range by 12%.
• In 2024, Johnson & Johnson partnered with a digital-instrument-tracking provider and piloted smart hand-held scalpels in 150 hospital theatres, boosting procedural throughput by ~8%.
• In early 2025, Aspen Surgical launched a new single-use hand-held retractor system and achieved deployment in over 3,000 ambulatory surgical centres within six months.
• In 2024, Medtronic opened a manufacturing facility dedicated to hand-held graspers and dilators, increasing global production capacity by approximately 18%.
• In 2025, B. Braun introduced a hand-held surgical instrument line manufactured using 30% recycled titanium alloy, targeting sustainability credentials and achieving >10% hospital adoption in first quarter.

Report Coverage of Hand-held Surgical Instruments Market

The Hand-held Surgical Instruments Market Report provides an in-depth coverage of global market size, share and trends across product types (forceps, retractors, dilators, graspers, scalpels, others) and end-use applications (hospitals, clinics, others). The report presents historical data from 2018-2023 and offers projections through 2030 and 2035. It also includes regional breakdowns covering North America (~41.2% share in 2024), Europe (~30% share in 2023), Asia-Pacific (~25% share in 2023) and Middle East & Africa (~6-8% share in 2024). Corporate profiles of top two companies (Smith & Nephew ~18% share; Johnson & Johnson ~15% share) are featured along with detailed competitive landscape analysis. Further, supply-chain insights such as sterilisation-downtime metrics (approximately 28% of facilities report delays) and hospital inventory replacement rates (~12% annually) are discussed. Both product innovation trends (e.g., digital-sensor hand-held instruments adopted by ~18% of ASCs in 2024) and investment flows (capital expenditure > USD 250 million in 2023) are included. The report offers actionable Hand-held Surgical Instruments Market Insights, Hand-held Surgical Instruments Market Size, Hand-held Surgical Instruments Market Share, and Hand-held Surgical Instruments Market Forecast for B2B stakeholders in hospitals, device manufacturers and suppliers.

Hand-held Surgical Instruments Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 20504.36 Million in 2026
Market Size Value By	USD 53701.03 Million by 2035
Growth Rate	CAGR of 12.11% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Forceps Retractors Dilators Graspers Scalpels Others By Application : Hospitals Clinics Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample